Two Sigma Advisers
MRNA icon

Two Sigma Advisers’s Moderna MRNA Stock Holding History

Two Sigma Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,729,700
Closed -$228M – 1332
2025
Q4 		$228M Buy
7,729,700
+956,800
+14% +$26M 0.44% 51
2025
Q3 		$175M Sell
6,772,900
-1,042,800
-13% -$29.1M 0.35% 74
2025
Q2 		$216M Buy
7,815,700
+4,007,200
+105% +$106M 0.44% 49
2025
Q1 		$108M Buy
3,808,500
+3,704,800
+3,573% +$131M 0.24% 87
2024
Q4 		$4.31M Sell
103,700
-252,800
-71% -$12.1M 0.01% 775
2024
Q3 		$23.8M Buy
+356,500
New +$32.7M 0.06% 284
2024
Q2 		– Sell
-3,500
Closed -$373K – 2597
2024
Q1 		$373K Sell
3,500
-31,300
-90% -$3.15M ﹤0.01% 1991
2023
Q4 		$3.46M Buy
+34,800
New +$2.93M 0.01% 984
2023
Q3 		– Sell
-23,900
Closed -$2.9M – 2502
2023
Q2 		$2.9M Buy
+23,900
New +$3.19M 0.01% 1008
2022
Q1 		– Sell
-14,225
Closed -$3.61M – 2844
2021
Q4 		$3.61M Sell
14,225
-447,800
-97% -$131M 0.01% 916
2021
Q3 		$178M Sell
462,025
-141,900
-23% -$52.3M 0.46% 52
2021
Q2 		$142M Buy
603,925
+446,100
+283% +$79.7M 0.37% 65
2021
Q1 		$20.7M Sell
157,825
-443,200
-74% -$64.2M 0.06% 352
2020
Q4 		$62.8M Buy
601,025
+497,825
+482% +$50.4M 0.17% 130
2020
Q3 		$7.3M Buy
+103,200
New +$7.2M 0.02% 626
2020
Q2 		– Sell
-7,600
Closed -$228K – 2562
2020
Q1 		$228K Buy
+7,600
New +$175K ﹤0.01% 2123
2019
Q3 		– Sell
-12,600
Closed -$184K – 2337
2019
Q2 		$184K Buy
+12,600
New +$271K ﹤0.01% 2145

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Advisers's MRNA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Moderna (MRNA) in Q1 2026, closing a stake of 7,729,700 shares — an estimated $228M sold.

Two Sigma Advisers first reported a position in MRNA in Q2 2019 and held it in 17 quarters. The position peaked at $228M in Q4 2025. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 7,729,700 Moderna shares in Q1 2026, an estimated $228M.
  • Two Sigma Advisers first reported a position in Moderna in Q2 2019 and held it in 17 quarters.
  • Two Sigma Advisers's Moderna position peaked at $228M in Q4 2025.
  • 725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.